PayerIQ
Sun, May 24, 2026
Back to universe
Tier 4AKCommercial
MDwise
Deprioritize — minimal contact + revisit annually
Composite
45.5
Rank
#233
Members
1.8M
Scoring profile
Six-criterion radar
Breakdown
Weighted score contribution
Claims
25%
41
+10.3
Lives
20%
51
+10.2
Geography
20%
43
+8.6
Restrictions
15%
21
+3.1
Relationship
10%
54
+5.4
Financials
10%
79
+7.9
Composite Score45.5
Composite = Claims×0.25 + Lives×0.20 + Geography×0.20 + Restrictions×0.15 + Relationship×0.10 + Financials×0.10
= 10.3 + 10.2 + 8.6 + 3.1 + 5.4 + 7.9 = 45.5
Intelligence
Qualitative intelligence
Members
1.8M
Drug spend
$0.5B
Formulary
4-tier
PA / RA level
Moderate
Biosimilar policy
No policy defined
Avg reimbursement
58 days
Strategic notes
Outperforms nationals in local market; key state champion opportunity
Playbook · Tier 4
Engagement timeline
Annually
Maintenance review · revisit tier